Provided by Tiger Trade Technology Pte. Ltd.

Revolution Medicines, Inc.

202.55
-0.8050-0.40%
Volume:660.92K
Turnover:132.95M
Market Cap:43.41B
PE:-22.70
High:206.36
Open:204.98
Low:197.81
Close:203.35
52wk High:224.31
52wk Low:42.18
Shares:214.34M
Float Shares:185.00M
Volume Ratio:1.21
T/O Rate:0.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.9212
EPS(LYR):-5.9502
ROE:-79.09%
ROA:-30.12%
PB:16.66
PE(LYR):-34.04

Loading ...

Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 26, 2025

Major Issues Report

Form 8-K - Current report
Feb 26, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 26, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 05, 2024

Major Issues Report

Form 8-K - Current report
Dec 04, 2024

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 02, 2024

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]